Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slava Polonsky

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|August 6, 2011
Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)Ilan Goldenberg, W Jackson Hall, Christopher A Beck, et al.
Journal of Cardiac Failure|December 24, 2013
The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudyMehmet K Aktas, Wojciech Zareba, David T Huang, et al.
Heart Rhythm|October 12, 2010
Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasiaGanesh S Kamath, Wojciech Zareba, Jessica Delaney, et al.
The American Journal of Cardiology|March 11, 2014
A metric for evaluating the cardiac response to resynchronization therapyYidi Ge, Anne-Christine Huth Ruwald, Valentina Kutyifa, et al.
Journal of the American College of Cardiology|March 2, 2013
The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)Valentina Kutyifa, Axel Kloppe, Wojciech Zareba, et al.
Heart Rhythm|July 23, 2013
Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRTColin L Doyle, David T Huang, Arthur J Moss, et al.
Heart Rhythm|March 28, 2009
Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillatorsIwona Cygankiewicz, John Gillespie, Wojciech Zareba, et al.
European Heart Journal|October 12, 2012
Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trialValentina Kutyifa, Wojciech Zareba, Scott McNitt, et al.
Circulation. Cardiovascular Genetics|August 12, 2011
Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutationAlon Barsheshet, Arthur J Moss, Scott McNitt, et al.
Heart Rhythm|March 15, 2011
Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndromeAlon Barsheshet, Derick R Peterson, Arthur J Moss, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|August 6, 2011
Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)Ilan Goldenberg, W Jackson Hall, Christopher A Beck, et al.
Journal of Cardiac Failure|December 24, 2013
The effect of weight loss on clinical outcomes in patients implanted with a cardiac resynchronization therapy device-A MADIT-CRT substudyMehmet K Aktas, Wojciech Zareba, David T Huang, et al.
Heart Rhythm|October 12, 2010
Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasiaGanesh S Kamath, Wojciech Zareba, Jessica Delaney, et al.
The American Journal of Cardiology|March 11, 2014
A metric for evaluating the cardiac response to resynchronization therapyYidi Ge, Anne-Christine Huth Ruwald, Valentina Kutyifa, et al.
Journal of the American College of Cardiology|March 2, 2013
The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy)Valentina Kutyifa, Axel Kloppe, Wojciech Zareba, et al.
Heart Rhythm|July 23, 2013
Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRTColin L Doyle, David T Huang, Arthur J Moss, et al.
Heart Rhythm|March 28, 2009
Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillatorsIwona Cygankiewicz, John Gillespie, Wojciech Zareba, et al.
European Heart Journal|October 12, 2012
Left ventricular lead location and the risk of ventricular arrhythmias in the MADIT-CRT trialValentina Kutyifa, Wojciech Zareba, Scott McNitt, et al.
Circulation. Cardiovascular Genetics|August 12, 2011
Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutationAlon Barsheshet, Arthur J Moss, Scott McNitt, et al.
Heart Rhythm|March 15, 2011
Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndromeAlon Barsheshet, Derick R Peterson, Arthur J Moss, et al.
Pageof 3